Wang C J, Li Y
Department of Bioengineering, Institute of Medicinal Biotechnology, CAMS, PUMC, Beijing 100050, China.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2001 Apr;23(2):154-7.
To express hsCTLA-4 in E. coli.
The hsCTLA-4 gene was obtained by PCR amplification from pE plasmid which contains CTLA-4 gene and was inserted into the expression vector pGEX-2T. The recombination strain was induced by IPTG with different concentrations and time.
The sequence of PCR amplified DNA fragments was identical with the reported CTLA-4 gene. SDS-PAGE and Western blot showed that 0.10 mmol/L IPTG can induce higher production of the fusion protein with molecular weight 40,000 after addition of IPTG 4 hours and GST-CTLA4 had immunological activity.
hsCTLA-4 can be expressed in soluble form high efficiency.
在大肠杆菌中表达人源可溶性细胞毒性T淋巴细胞相关抗原4(hsCTLA-4)。
从含CTLA-4基因的pE质粒中通过PCR扩增获得hsCTLA-4基因,并将其插入表达载体pGEX-2T。用不同浓度和时间的异丙基-β-D-硫代半乳糖苷(IPTG)诱导重组菌株。
PCR扩增的DNA片段序列与报道的CTLA-4基因一致。十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)和蛋白质免疫印迹法(Western blot)显示,0.10 mmol/L IPTG在加入4小时后可诱导产生更高产量的分子量为40000的融合蛋白,且谷胱甘肽S-转移酶-CTLA4(GST-CTLA4)具有免疫活性。
hsCTLA-4可高效以可溶性形式表达。